ArticleExperimental hematology & oncology2025

IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response.

Mingyue Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.